Relmada Therapeutics Inc

NASDAQ:RLMD   4:00:00 PM EDT
4.30
-0.38 (-8.12%)
7:26:55 PM EDT: $4.30 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Relmada Therapeutics Inc Stock, NASDAQ:RLMD

2222 Ponce de Leon Boulevard, 3rd floor, Coral Gables, Florida 33134
United States of America
Phone: +1.786.629.1376
Number of Employees: 20
http://www.relmada.com

Description

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.